NYSE$CON

Concentra Group Holdings · Q4 2025 earnings

Q4 2025 earnings · · After market close · Investor relations

Briefing

Concentra Group reported Q4 2025, revenue of $539.1M, net income of $36.2M.

For Q4 2025, Concentra Group reported revenue of $539.1M, net income of $36.2M. Management discusses segment performance, capital allocation, and macro risks in the quarterly filing.

  • Revenue $539.1M.
  • Net income $36.2M.
  • Concentra Group MD&A covers liquidity, credit, and operating priorities.

Headline financials

Total Revenue

$539M

Previous: $465M+15.9%
EPS (adj)

$0.28

Previous: $0.17+64.7%
Adjusted EBITDA

$95.3M

Previous: $77.5M+22.9%
Adjusted EBITDA Margin

17.7%

Previous: 16.7%+6.0%
Net Income Margin

6.7%

Previous: 4.9%+36.7%
Total Patient Visits

3.3M

Previous: 3.0M+9.0%
Visits Per Day

51.0K

Previous: 46.8K+9.0%
Revenue Per Visit

$149.63

Previous: $145.08+3.1%
Total Occupational Health Centers

628

Previous: 552+13.8%
Total Onsite Health Clinics

411

Previous: 157+161.8%
Cash Balance

$79.9M

No prior period
Net Leverage Ratio

3.4

No prior period
Net Income

$36.2M

Previous: $22.8M+58.8%
Operating Income

$69.7M

Previous: $59.1M+17.9%

Revenue & EPS history

Concentra Group Holdings · Revenue · Quarterly

$539M

Q4 2025+15.9%vs Q4 2024
Beat estimate in 6 of 7 quarters(86%)
ActualEstimate

Revenue by segment

Concentra Group Holdings · $468K total across 3 segments · Q1 2024

  • Occupational Health Centers
    $441K
  • Onsite Health Clinics
    $15.9K
  • Other
    $10.7K

Forward guidance

The quarterly filing discusses operating priorities, capital returns, and sector risks; numeric multi-quarter bridges vary by issuer.

Tailwinds

  • MD&A highlights liquidity, capital, and core business trends.
  • Segment or product commentary supports the earnings narrative.

Headwinds

  • Macro, rates, or input costs may pressure near-term margins.
  • One-time items can affect year-over-year comparability.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 7 quarterly earnings reports · overlaid with Q4 2025

Historical avgQ4 2025

-0.2%

Avg return

Earnings day

+0.9%

Avg return

5 days after

+1.4%

Avg return

30 days after

56%

5 / 9 earnings

Positive

+3.2%

Q1 2026

Best reaction

-3.7%

Q1 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+3.2%+11.6%+10.6%
Q4 2025+1.4%-0.3%-10.7%
Q3 2025+3.1%+6.7%+4.1%
Q1 2025-3.7%-2.1%+0.7%
Q4 2024+0.3%-0.7%-1.4%
Q3 2023+2.3%+0.4%+3.5%
Q3 2024-3.4%-5.8%+5.0%
Q2 2023-2.1%+3.4%-4.1%
Q2 2024-2.8%-5.3%+4.9%
Q1 2024
Q4 2023
Q1 2023

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro